Abstract:A series of novel ligustrazine-chalcone hybrids were synthesized and evaluated for their in vitro and in vivo antitumor activities. The results showed that most of these compounds exhibited significant in vitro cytotoxicity against MDA-MB-231, MCF-7, A549 and HepG2 cell lines with IC50 values as low as sub-micromole. Among them, compounds 6c and 6f possessed better comprehensive characteristics for the antiproliferation effects on both MDA-MB-231 (IC50: 6c, 1.60 +/- 0.21 mu M; 6f, 1.67 +/- 1.25 mu M) and MCF-7 (IC50: 6c, 1.41 +/- 0.23 mu M; 6f, 1.54 +/- 0.30 mu M). They also exhibited the potent colony-formation inhibitory abilities on above two cell lines in both concentration and time dependent manners, as well as the significantly suppression capabilities against the migration of such cell lines in a concentration dependent manner by wound-healing assay. Of note, compound 6c could significantly induce the apoptosis of MDA-MB-231 cells in a concentration dependent manner and inhibited the transformation of the growth cycle of MDA-MB-231 cells and blocked the cell growth cycle in G0/ G1 phase. Moreover, the in vivo antiproliferation assay of compound 6c on TNBC model indicated such compound had a remarkable potency against tumor growth with a widely safety window. Further immunohistochemistry analysis illustrated that compound 6c was provided with a potent capacity to significantly reduce the Ki-67 positive rate in a dose dependent manner. All the results suggested that these hybrids presented both in vitro and in vivo proliferation inhibition potency against breast cancer and further development with good therapeutic potential should be of great interest.

Design, Synthesis and Antiproliferative Activity of Chrysin Derivatives Bearing Triazole Moieties

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Design, Synthesis and Biological Evaluation of Chrysin Long-Chain Derivatives As Potential Anticancer Agents

Design, Synthesis and Biological Evaluation of Chrysin Benzimidazole Derivatives As Potential Anticancer Agents

Design, Synthesis, and Anticancer Activity of Novel Trimethoxyphenyl-Derived Chalcone-Benzimidazolium Salts

Design, Synthesis and Evaluation of Structurally Diverse Chrysin-Chromene-spirooxindole Hybrids As Anticancer Agents.

Design, Synthesis, and Anticancer Activity of Novel 4,6-Dimorpholinyl-1,3,5-triazine Compounds

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

Synthesis and Evaluation of Antitumour Activity in Vitro and in Vivo of Chrysin Salicylate Derivatives

Synthesis of Novel Amino Acid Derivatives Containing Chrysin As Anti-Tumor Agents Against Human Gastric Carcinoma MGC-803 Cells

Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents.

Synthesis and antitumor activity of novel chalcone derivatives.

Synthesis, Molecular Modeling and Biological Evaluation of Chalcone Thiosemicarbazide Derivatives As Novel Anticancer Agents.

Synthesis of New 7-O-modified Chrysin Derivatives and Their Anti-Proliferative and Apoptotic Effects on Human Gastric Carcinoma MGC-803 Cells

Synthesis and Anti-Proliferative Activities of 5,6,7-Trimethoxyflavones and Their Derivatives

Syntheses and Anticancer Activities of Glycine Derivatives of Chrysin

Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.

Synthesis and Biological Evaluation of Novel Ligustrazine-Chalcone Derivatives As Potential Anti-Triple Negative Breast Cancer Agents

Synthesis and in vitro antitumor activity evaluation of novel 5-cyano-6-phenyl-2,4-disubstituted-pyrimidine derivatives

Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents